首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Direct patient reporting of adverse drug reactions: An analysis of spontaneous reports submitted to Malaysian pharmacovigilance centre
【24h】

Direct patient reporting of adverse drug reactions: An analysis of spontaneous reports submitted to Malaysian pharmacovigilance centre

机译:直接向患者报告不良药物反应:提交给马来西亚药物警戒中心的自发报告的分析

获取原文
           

摘要

Purpose: To evaluate patient adverse drug reaction (ADR) reports in terms of categories by System Organ Class (SOC), suspected products and seriousness. Methods: The national database was retrospectively searched from 2008 to 2015. ADR reports by patients were included but vaccine-related reports and reports by healthcare professionals were excluded. Eligible reports were analysed descriptively and Chi-square test was used to evaluate the association of various categorical variables with serious ADRs. Results: Of the total of 75,391 reports screened in the National ADR database for the study period, only 81 (0.11 %) were reports from patients, of which 32 (40 %) reports involved serious ADRs. The majority of reports was associated with unregistered products or unapproved cosmetics. Half of the reports involved traditional products while cosmetic products constituted another 10 % of the reports. The three main SOCs involved were skin and appendages disorders (26 %), body as a whole (25 %), and central and peripheral nervous system disorders (9 %). A total of 23 out of 47 products tested were adulterated with prescription drugs while 4 cosmetic products exceeded the permitted limit for hydroquinone or mercury. Two factors found to be significantly associated with serious ADRs were product registration status and presence of adulteration. Conclusion: The findings indicate that patient reporting of suspected ADRs has the potential to add valuable information to pharmacovigilance.
机译:目的:根据系统器官类别(SOC),可疑产品和严重性对患者不良药物反应(ADR)报告进行评估。方法:回顾性分析2008年至2015年的国家数据库,包括患者的ADR报告,但不包括疫苗相关的报告和医护人员的报告。对合格的报告进行描述性分析,并使用卡方检验评估各种分类变量与严重ADR的关联。结果:在研究期间,在国家ADR数据库中筛选的75,391份报告中,只有81份(0.11%)是患者报告,其中32份(40%)报告涉及严重ADR。大多数报告与未注册产品或未经批准的化妆品有关。报告的一半涉及传统产品,而化妆品占报告的10%。涉及的三个主要SOC是皮肤和附件疾病(26%),整个身体(25%)以及中枢和周围神经系统疾病(9%)。在测试的47种产品中,共有23种产品掺有处方药,而4种化妆品超过了对苯二酚或汞的允许限量。发现与严重ADR显着相关的两个因素是产品注册状态和掺假。结论:研究结果表明,对可疑ADR的患者报告有可能为药物警戒增加有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号